openPR Logo
Press release

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ Set to Climb to USD 5.95 Billion by 2030

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ is expected to reach USD 5.95 Bn by 2030 from USD 2.22 Bn in 2023, at a CAGR of 15.1% during the forecast period.

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

The global anti-obesity drugs market is witnessing significant growth driven by the escalating rates of obesity and overweight individuals. These medications aim to facilitate weight loss by regulating appetite and calorie intake, thereby addressing the rising health concerns associated with obesity, such as cardiovascular diseases and type II diabetes. With a growing demand for effective and long-lasting anti-obesity treatments, pharmaceutical companies are actively engaged in research and development to create innovative solutions.

๐˜๐จ๐ฎ๐ซ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ˆ๐ฌ ๐‰๐ฎ๐ฌ๐ญ ๐š ๐‚๐ฅ๐ข๐œ๐ค ๐€๐ฐ๐š๐ฒ! https://www.maximizemarketresearch.com/request-sample/100768/

๐ƒ๐ซ๐ข๐ฏ๐ž๐ซ๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ:

The primary driver of the anti-obesity drugs market is the increasing prevalence of obesity worldwide, attributed to sedentary lifestyles and unhealthy eating habits. According to the World Health Organization, the number of overweight adults has surged in recent years, prompting the need for effective pharmacological interventions. Additionally, partnerships among leading pharmaceutical companies to develop new drug formulations further enhance market growth, addressing the demand for treatments that can provide sustained weight management.

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ:

A notable trend in the anti-obesity drugs market is the focus on dual-action medications that can simultaneously address obesity and related metabolic disorders, such as type II diabetes. Companies are increasingly investing in clinical trials for these combination therapies, aiming to enhance treatment efficacy and patient compliance. Furthermore, advancements in personalized medicine are paving the way for tailored anti-obesity solutions, catering to the unique needs of individual patients.

๐๐ž๐ž๐ ๐Œ๐จ๐ซ๐ž ๐ˆ๐ง๐Ÿ๐จ๐ซ๐ฆ๐š๐ญ๐ข๐จ๐ง? ๐ˆ๐ง๐ช๐ฎ๐ข๐ซ๐ž ๐€๐›๐จ๐ฎ๐ญ ๐’๐š๐ฆ๐ฉ๐ฅ๐ž + ๐†๐ซ๐š๐ฉ๐ก๐ฌ ๐‡๐ž๐ซ๐ž: https://www.maximizemarketresearch.com/inquiry-before-buying/100768/

๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ:

The anti-obesity drugs market presents ample opportunities for growth, particularly with the rising demand for effective weight management solutions. The development of new drugs with long-term efficacy and fewer side effects is expected to attract more patients seeking treatment. Additionally, emerging markets are identified as a potential hotspot for growth, as increasing disposable incomes and urbanization lead to lifestyle changes that may heighten obesity rates.

๐–๐ก๐š๐ญ ๐ข๐ฌ ๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐ˆ๐ง๐ฌ๐ข๐ ๐ก๐ญ?

North America is anticipated to dominate the anti-obesity drugs market during the forecast period, driven by a high prevalence of obesity and extensive healthcare infrastructure. The region's focus on innovative treatment solutions and the presence of major pharmaceutical companies contribute to its market leadership. However, the Asia-Pacific region is emerging as a key area for growth due to rising awareness of obesity-related health issues and increasing investment in healthcare, positioning it as a future growth frontier for anti-obesity drug development.

๐‚๐ฎ๐ซ๐ข๐จ๐ฎ๐ฌ ๐ญ๐จ ๐ฉ๐ž๐ž๐ค ๐ข๐ง๐ฌ๐ข๐๐ž? ๐†๐ซ๐š๐› ๐ฒ๐จ๐ฎ๐ซ ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐จ๐Ÿ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ ๐ง๐จ๐ฐ:๏ปฟ https://www.maximizemarketresearch.com/request-sample/100768/ ๏ปฟ๏ปฟ

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ

by Mechanism of Action

Peripherally Acting Drugs
Centrally Acting Drugs

by Drug Type

Prescription Drugs
OTC Drugs

by Distribution Channel

Hospitals Pharmacies
Retail Pharmacies
E-commerce

๐–๐ก๐จ ๐ข๐ฌ ๐ญ๐ก๐ž ๐ฅ๐š๐ซ๐ ๐ž๐ฌ๐ญ ๐ฆ๐š๐ง๐ฎ๐Ÿ๐š๐œ๐ญ๐ฎ๐ซ๐ž๐ซ๐ฌ ๐จ๐Ÿ ๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐ฐ๐จ๐ซ๐ฅ๐๐ฐ๐ข๐๐ž?

North America
1. Icahn Enterprises
2. Pfizer
3. Orexigen Therapeutics
4. Bristol-Myers Squibb

Europe
5. Novo Nordisk
6. Roche
7. Norgine
8. GSK
9. Saniona
10. AstraZeneca
11. Hikma Pharmaceuticals

APAC
12. Eisai
13. Takeda Pharmaceutical Company
14. Sanofi India
15. Sun Pharmaceutical Industries
16. Teijin Pharma
17. Kowa
18. Cipla
19. Torrent Pharmaceuticals
20. Zydus Lifesciences
21. Glenmark Pharmaceuticals

Middle East
22. Teva Pharmaceutical Industries
23. Gulf Pharmaceutical Industries
24. Saudi Pharmaceutical Industries & Medical Appliances
25. The Jordanian Pharmaceutical Manufacturing Company

South America
26. Eurofarma Laboratorios

๐†๐ž๐ญ ๐ƒ๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐Ž๐ง ๐“๐ก๐ž ๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐Ž๐Ÿ ๐“๐ก๐ข๐ฌ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ @ https://www.maximizemarketresearch.com/market-report/global-anti-obesity-drugs-market/100768/ ๏ปฟ๏ปฟ๏ปฟ๏ปฟ

๐Š๐ž๐ฒ ๐Ž๐Ÿ๐Ÿ๐ž๐ซ๐ข๐ง๐ ๐ฌ:

Past Market Size and Competitive Landscape
Coffee Beans Market Size, Share, Size & Forecast by different segment
Market Dynamics - Growth Drivers, Restraints, Opportunities, and Key Trends by region
Coffee Beans Market Segmentation - A detailed analysis by Product
Competitive Landscape - Profiles of selected key players by region from a strategic perspective
Competitive landscape - Market Leaders, Market Followers, Regional player
Competitive benchmarking of key players by region
PESTLE Analysis
PORTER's analysis
Value chain and supply chain analysis
Legal Aspects of business by region
Lucrative business opportunities with SWOT analysis
Recommendations

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐จ๐ฎ๐ซ ๐ญ๐จ๐ฉ-๐ฉ๐ž๐ซ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ๐ฌ ๐จ๐ง ๐ญ๐ก๐ž ๐ฅ๐š๐ญ๐ž๐ฌ๐ญ ๐ญ๐ซ๐ž๐ง๐๐ฌ:

โ™ฆ Second hand Product Market https://www.maximizemarketresearch.com/market-report/second-hand-product-market/191282/

โ™ฆ Copper Sputtering Target Market https://www.maximizemarketresearch.com/market-report/copper-sputtering-target-market/191378/

โ™ฆ Baby Safety Products Market https://www.maximizemarketresearch.com/market-report/baby-safety-products-market/191570/

โ™ฆ Semiconductor Chip Ecosystem Market https://www.maximizemarketresearch.com/market-report/semiconductor-chip-ecosystem-market/191645/

โ™ฆ Plastic Pipe Fitting Market https://www.maximizemarketresearch.com/market-report/plastic-pipe-fitting-market/193889/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

MAXIMIZE MARKET RESEARCH PVT. LTD.
โฎ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
โœ† +91 9607365656
๐Ÿ–‚ sales@maximizemarketresearch.com
๐ŸŒ www.maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐Œ๐š๐ฑ๐ข๐ฆ๐ข๐ณ๐ž ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฌ๐ž๐š๐ซ๐œ๐ก:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release ๐€๐ง๐ญ๐ข-๐Ž๐›๐ž๐ฌ๐ข๐ญ๐ฒ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ Set to Climb to USD 5.95 Billion by 2030 here

News-ID: 3708465 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD

Wine Production Machinery Market Growing at a Robust CAGR of 6.4% Driven by Automation and Premium Wine Demand
Wine Production Machinery Market Growing at a Robust CAGR of 6.4% Driven by Auto โ€ฆ
The Wine Production Machinery Market size was valued at USD 2.64 Billion in 2025 and the total Wine Production Machinery revenue is expected to grow at a CAGR of 6.4% from 2026 to 2032, reaching nearly USD 4.08 Billion by 2032. Wine Production Machinery Market Overview: The Wine Production Machinery Market is witnessing steady transformation as wineries across the globe increasingly adopt modern equipment to enhance efficiency, consistency, and product quality. Fromโ€ฆ
Fusion Energy Market Outlook Highlights Strong Growth at 7.4% CAGR
Fusion Energy Market Outlook Highlights Strong Growth at 7.4% CAGR
The Fusion Energy Market size was valued at USD 347.48 Billion in 2025 and the total Fusion Energy revenue is expected to grow at a CAGR of 7.4% from 2026 to 2032, reaching nearly USD 572.74 Billion by 2032. Fusion Energy Market Overview: The Fusion Energy Market is gaining global attention as nations, industries, and researchers intensify efforts to develop cleaner and more sustainable power alternatives for the future. Fusion energy isโ€ฆ
India Gold Loan Market Shows Strong Momentum Driven by Trust, Technology, and Financial Inclusion
India Gold Loan Market Shows Strong Momentum Driven by Trust, Technology, and Fi โ€ฆ
The India Gold Loan Market size was valued at USD 67.40 Billion in 2024 and the total India Gold Loan Market is expected to grow at a CAGR of 12.30 % from 2025 to 2032, reaching nearly USD 170.49 Billion. India Gold Loan Market Overview: The India Gold Loan Market has steadily evolved into a trusted financial solution for individuals and small businesses seeking quick access to funds without liquidating their long-termโ€ฆ
Coffee Beans Market Trends Highlight Rising Demand for Specialty, Sustainable, and Premium Coffee Worldwide
Coffee Beans Market Trends Highlight Rising Demand for Specialty, Sustainable, a โ€ฆ
The Coffee Beans Market size was valued at USD 36.41 Billion in 2024 and the total Coffee Beans revenue is expected to grow at a CAGR of 6.8% from 2025 to 2032, reaching nearly USD 61.64 Billion. Coffee Beans Market Overview: The Coffee Beans Market reflects a complex ecosystem that begins at farms and extends to global distribution networks. Coffee beans are cultivated across diverse climatic regions, each contributing unique taste profilesโ€ฆ

All 5 Releases


More Releases for Pharma

Schizophrenia Market: Expanding Revenue Landscape to 2034 - DelveInsight | Teva โ€ฆ
The Key Schizophrenia Companies in the market inlclude - Teva Pharmaceutical Industries, Royalty Pharma, MedinCell, Sumitomo Pharma, Otsuka Pharmaceuticals, Reviva Pharmaceuticals, Minerva Neurosciences, Mitsubishi Tanabe Pharma, Lundbeck, Intra-cellular Therapies, Sumitomo Pharma, Otsuka Pharma, Reviva Pharmaceuticals, and others. DelveInsight's report "Schizophrenia Market Insights, Epidemiology, and Market Forecast-2034" provides a comprehensive analysis of the Schizophrenia landscape. The report delivers detailed insights into the disease, including historical and projected epidemiology, helping stakeholders understand theโ€ฆ
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USDย 22.32ย Billion by 2024. The valuation is expected to reach USDย 47.79ย Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of theโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasingโ€ฆ
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi โ€ฆ
๐”๐’๐€, ๐๐ž๐ฐ ๐‰๐ž๐ซ๐ฌ๐ž๐ฒ- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. Asโ€ฆ
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh โ€ฆ
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of theโ€ฆ
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, โ€ฆ
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoringโ€ฆ